会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Sensor-based athletic activity measurements
    • 基于传感器的运动活动测量
    • US09446287B2
    • 2016-09-20
    • US13175216
    • 2011-07-01
    • Aaron B. WeastJames M. Mullin
    • Aaron B. WeastJames M. Mullin
    • G01C22/00H03F1/26A63B24/00A61B5/11A61B5/00
    • A63B24/0062A61B5/1036A61B5/112A61B5/1123A61B5/486A61B5/6807A61B5/7257A61B2503/10A63B2024/0065A63B2220/20A63B2220/836A63B2230/75
    • Determining pace or speed based on sensor data may include determining an amount of contact time a user's foot has with a workout surface such as the ground. Contact time may be determined by identifying samples in the sensor data that correspond to various events such as a heelstrike, a toe-off and a subsequent heelstrike. In one example, these events may be identified by determining a sequence of three sample values (e.g., a triplet) that exceeds corresponding thresholds. The validity of an identified triplet (e.g., heelstrike, toe-off and heelstrike) may be confirmed by determining whether a difference between a last event sample and a middle event sample is greater than a difference between the middle event sample and an initial event sample. Once confirmed, a contact time may be determined from the triplet. A linear or non-linear relationship may then be applied to the contact time to determine a speed or pace.
    • 基于传感器数据确定速度或速度可以包括确定用户的脚具有诸如地面的锻炼表面的接触时间量。 接触时间可以通过识别传感器数据中对应于各种事件的样品来确定,诸如脚跟,脚趾和随后的脚后跟。 在一个示例中,可以通过确定超过相应阈值的三个样本值(例如,三元组)的序列来识别这些事件。 可以通过确定最后事件样本和中间事件样本之间的差异是否大于中间事件样本和初始事件样本之间的差异来确认识别的三元组(例如,脚跟,脚趾和脚跟)的有效性 。 一旦确认,可以从三元组确定接触时间。 然后可以将线性或非线性关系应用于接触时间以确定速度或速度。
    • 9. 发明授权
    • Compositions and methods for the prevention of esophageal cancer
    • 预防食管癌的组成和方法
    • US09339516B2
    • 2016-05-17
    • US14114236
    • 2012-05-07
    • James M. MullinJonathan Raines
    • James M. MullinJonathan Raines
    • A61K33/30A61K31/315A61K9/20
    • A61K33/30A61K31/315
    • Methods of inhibiting Barrett's esophagus and/or adenocarcinoma in a subject are provided. In a particular embodiment, the method comprises administering at least one composition comprising at least one zinc compound and at least one pharmaceutically acceptable carrier to the esophagus of the subject. The zinc may be a pharmaceutically acceptable salt of zinc, such as zinc gluconate. The zinc may be administered, for example, orally, topically, or by an implantable medical device. In a particular embodiment, the methods further comprise administering at least one analgesic, anesthetic, or other therapeutic agent or therapy for the treatment of Barrett's esophagus. The method may further comprise monitoring the progression of Barrett's esophagus in the subject.
    • 提供了抑制受试者中Barrett食管和/或腺癌的方法。 在一个具体实施方案中,所述方法包括向受试者的食道施用至少一种包含至少一种锌化合物和至少一种药学上可接受的载体的组合物。 锌可以是药学上可接受的锌盐,例如葡萄糖酸锌。 锌可以例如口服,局部施用或通过可植入医疗装置施用。 在一个具体实施方案中,所述方法还包括施用至少一种止痛剂,麻醉剂或其它治疗剂或治疗用于治疗巴雷特氏食管。 该方法还可以包括监测受试者中Barrett食管的进展。